Related Experiment Video
Updated: May 8, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
A Staged Approach to the Number and Frequency of Visual Field Testing for Detecting Glaucoma Progression
Jack Phu1, Henrietta Wang2, Michael Kalloniatis3
1School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Kensington, New South Wales, Australia; School of Optometry and Vision Science, University of New South Wales, Kensington, New South Wales, Australia; University of Houston College of Optometry, Houston, Texas.
Purpose:
To assess a staged visual field review model (initially intensive, then downtitrated) for detecting cases of glaucoma progression (especially catastrophic and fast), in comparison to clinical standard, fixed review approaches.
Design:
A computer simulation study.
Subjects:
A total of 100 000 subjects.
Methods:
A total of 100 000 subjects were simulated to undergo 4 visual field tests in 1 "eye" per visit, every 3 months, over 30 years. The staged visual field model consisted of an initial intensive review (e.g., 3 tests per eye per visit, every 3 months) that was then downtitrated as 90% of progressors within a rate bin (e.g., catastrophic <-2 dB/year) were detected. The test number and review cadence were systematically downtitrated with 90% of successive progression-rate bins detected until the end of the 30-year follow-up. Comparator models were fixed reviews: 1 test every 12 months, 1 test every 6 months, 2 tests every 6 months ("frontloading"), and 3 tests every 24 months ("wait-and-see"). To reduce false positives, an immediate subsequent confirmatory progression result was required for all conditions.
Main Outcome Measures:
Number of progressors detected and number of tests/visits required per case of progression detected.
Results:
All staged review approaches detected 90% of catastrophic (21-36 months) and fast (36-60 months) progression bins sooner compared to all fixed methods (catastrophic: 66-108 months; fast: 84-132 months) except fixed frontloading. Detection of 50% of all progressors was also achieved sooner for the staged approaches (21-36 months) compared to all fixed methods (60-96 months), except for fixed frontloading (36 months). When using 1 test every 12 months as a reference standard, the staged approaches were 66% to 251% more likely to detect progression. The 2 tests per visit at every 3 and 6 months staged intervals were the most efficient with the lowest number of visits (10.6 and 8.6 at 5 years) and tests (15.8 and 12.9 at 5 years) per case detected over time.
Conclusions:
A staged visual field review model starting with intensive testing (such as 2 tests per visit at every 3 or 6 months intervals) with downtitration at 30-36 months may increase the likelihood of detecting progressors and may provide long-term efficiencies in case detection, in comparison to conventional fixed approaches.
Financial Disclosure(S):
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
